Concepedia

Araceli Lérida‐Viso

AL

6

Publications

405

Citations

6

H-Index

2020

Active since

Affiliations

Universitat Politècnica de València(Current)

Instituto de Investigación Sanitaria La Fe

Centro de Investigacion Principe Felipe

Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine

Universitat de València

Araceli Lérida‐Viso is an author at Universitat Politècnica de València specializing in medicine, pharmacology, and cancer cell biology.

ORCID

Top concepts

Publications per year

2020–2022

6

Publications

6

Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity

Estela González‐Gualda, Marta Pàez‐Ribes, Beatriz Lozano‐Torres et al. · Aging Cell · 2020 · 260 citations · Full text

Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice

Araceli Lérida‐Viso, Alejandra Estepa‐Fernández, Ángela Morellá‐Aucejo et al. · Pharmacological Research · 2022 · 65 citations · Full text

, , +10

Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer

Alejandra Estepa‐Fernández, Alba García‐Fernández, Araceli Lérida‐Viso et al. · Pharmacological Research · 2022 · 36 citations · Full text

Senolysis Reduces Senescence in Veins and Cancer Cell Migration

Alejandra Estepa‐Fernández, María Alfonso, Ángela Morellá‐Aucejo et al. · Advanced Therapeutics · 2021 · 18 citations

, , +14

Engineering nanoparticle communication in living systems by stigmergy: An application to enhance antitumor therapy in triple-negative breast cancer

Alejandra Estepa‐Fernández, Alba García‐Fernández, Araceli Lérida‐Viso et al. · Nano Today · 2022 · 15 citations · Full text

, , +11

Rows per page

1–5 of 6